中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2014年
31期
37-38
,共2页
病毒性呼吸道感染%小儿%干扰素%临床疗效
病毒性呼吸道感染%小兒%榦擾素%臨床療效
병독성호흡도감염%소인%간우소%림상료효
Viral respiratory infection%Children%Interferon%Clinical curative effect
目的：探讨干扰素肌注及雾化吸入治疗小儿病毒性呼吸道感染的临床疗效。方法：2013年6月-2014年6月收治病毒性呼吸道感染患儿240例，年龄3个月～12岁，随机分为A、B、C组，各80例。A组应用重组人干扰素-α1b肌注，B组应用重组人干扰素-α1b雾化治疗，C组使用其他药物雾化吸入，比较3组的临床疗效。结果：B组的治疗总有效率(93.75％)显著高于A组(86.25％)和C组(78.75％)，差异具有统计学意义(P＜0.05)。B组的退热时间与A组和C组比较显著缩短，差异具有统计学意义(P＜0.05)。治疗过程中均未见不良反应。结论：干扰素雾化治疗小儿病毒性呼吸道感染疗效显著，不良反应少，值得在临床中推广应用。
目的：探討榦擾素肌註及霧化吸入治療小兒病毒性呼吸道感染的臨床療效。方法：2013年6月-2014年6月收治病毒性呼吸道感染患兒240例，年齡3箇月～12歲，隨機分為A、B、C組，各80例。A組應用重組人榦擾素-α1b肌註，B組應用重組人榦擾素-α1b霧化治療，C組使用其他藥物霧化吸入，比較3組的臨床療效。結果：B組的治療總有效率(93.75％)顯著高于A組(86.25％)和C組(78.75％)，差異具有統計學意義(P＜0.05)。B組的退熱時間與A組和C組比較顯著縮短，差異具有統計學意義(P＜0.05)。治療過程中均未見不良反應。結論：榦擾素霧化治療小兒病毒性呼吸道感染療效顯著，不良反應少，值得在臨床中推廣應用。
목적：탐토간우소기주급무화흡입치료소인병독성호흡도감염적림상료효。방법：2013년6월-2014년6월수치병독성호흡도감염환인240례，년령3개월～12세，수궤분위A、B、C조，각80례。A조응용중조인간우소-α1b기주，B조응용중조인간우소-α1b무화치료，C조사용기타약물무화흡입，비교3조적림상료효。결과：B조적치료총유효솔(93.75％)현저고우A조(86.25％)화C조(78.75％)，차이구유통계학의의(P＜0.05)。B조적퇴열시간여A조화C조비교현저축단，차이구유통계학의의(P＜0.05)。치료과정중균미견불량반응。결론：간우소무화치료소인병독성호흡도감염료효현저，불량반응소，치득재림상중추엄응용。
Objective:To explore the curative effect comparing of interferon intramuscular injection and atomizing in the treatment of pediatric viral respiratory infection.Methods:240 cases of children with viral respiratory infection aged 3~12 years old from June 2013 to June 2014 were randomly divided into group A,B,C group with 80 cases in each group.Group A accepted epoetin interferon alpha 1b intramuscular injection;group B accepted epoetin interferon alpha 1 B atomization treatment;group C accepted other atomization inhalation.We compared the clinical effect of the three groups.Results:The total effective rate of group B (93.75) was significantly higher than that of group A(86.25) and group C(78.75),and the difference was statistically significant(P<0.05).Compared with group A and group C,the defervescence time of group B was significantly shortened, with statistically significant difference(P<0.05).Treatment of adverse reaction was not found in the process.Conclusion:The therapeutic effect of interferon atomization in the treatment of infantile viral respiratory infection is obvious and has few adverse reactions,which is worthy of clinical popularization and application.
